SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-165858
Filing Date
2017-05-10
Accepted
2017-05-10 16:09:03
Documents
6
Effectiveness Date
2017-05-10

Document Format Files

Seq Description Document Type Size
1 DEFA14A d379739ddefa14a.htm DEFA14A 34861
2 GRAPHIC g379739notarrow.jpg GRAPHIC 2830
3 GRAPHIC g379739notpg001.jpg GRAPHIC 1313
4 GRAPHIC g379739notpg002.jpg GRAPHIC 1353
5 GRAPHIC g379739notpg003.jpg GRAPHIC 1329
6 GRAPHIC g379739notpg004.jpg GRAPHIC 1364
  Complete submission text file 0001193125-17-165858.txt   47994
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36279 | Film No.: 17830291
SIC: 2834 Pharmaceutical Preparations